A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma

Radiotherapy and Oncology

Volumn 69, Issue 1, 2003, Pages 53-62

  Hui, Edwin P ^a   Poon, Terence C W ^a   Teo, Peter M L ^a   Mo, Frankie ^a   Zee, Benny ^a   Leung, Sing F ^a   Ho, Stephen ^a   Mok, Tony S K ^a   Kwan, Wing H ^a   Johnson, Philip J ^a   Chan, Anthony T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bromodeoxyuridine; Flow cytometry; Ki 67; Nasopharyngeal carcinoma; Potential doubling time

Indexed keywords

BROXURIDINE; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL KINETICS; CELL LABELING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTODIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 10744223489     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00248-2     Document Type: Article

References (33)

1. Alsner J., Hoyer M., Sorensen S.B., Overgaard J. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 49:(2):2001;519-525.
2. Begg A.C., Haustermans K., Hart A.A., et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol. 50:(1):1999;13-23.
3. Begg A.C., Hofland I., Moonen L., et al. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys. 19:(6):1990;1449-1453.
4. Begg A.C., McNally N.J., Shrieve D.C., Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 6:(6):1985;620-626.
5. Bennett M.H., Wilson G.D., Dische S., et al. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer. 65:(6):1992;870-878.
6. Bourhis J., Dendale R., Hill C., et al. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks. Int J Radiat Oncol Biol Phys. 35:(3):1996;471-476.
7. Chan A.T., Ho S., Teo P.M., et al. In vitro uptake of bromodeoxyuridine by human nasopharyngeal carcinoma (NPC) and its relation to clinical findings. Eur J Cancer B Oral Oncol. 32B:(1):1996;50-54.
8. Chan A.T., Ho S., Teo P.M., et al. Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings. Oral Oncol. 33:(1):1997;13-18.
9. Chan A.T., Teo P.M., Leung T.W., Johnson P.J. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer. 82:(6):1998;1003-1012.
10. Chan A.T., Teo P.M., Ngan R.K., et al. Concurrent chemotherapy- radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol. 20:(8):2002;2038-2044.
11. Cheng D.S., Campbell B.H., Clowry L.J., et al. DNA content in nasopharyngeal carcinoma. Am J Otolaryngol. 11:(6):1990;393-397.
12. Corvo R., Giaretti W., Sanguineti G., et al. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol Biol Phys. 27:(5):1993;1165-1172.
13. Corvo R., Giaretti W., Sanguineti G., et al. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J Clin Oncol. 13:(8):1995;1843-1850.
14. Costello F., Mason B.R., Collins R.J., Kearsley J.H. A clinical and flow cytometric analysis of patients with nasopharyngeal cancer. Cancer. 66:(8):1990;1789-1795.
15. Fleming I.D., Cooper J.S., Henson D.E., et al. American joint committee on cancer: AJCC cancer staging manual. 5th ed. 1997;Lippincott-Raven, Philadelphia, PA.
16. Gerdes J., Li L., Schlueter C., et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 138:(4):1991;867-873.
17. Haustermans K., Fowler J.F. Is there a future for cell kinetic measurements using IdUrd or BdUrd? Int J Radiat Oncol Biol Phys. 49:(2):2001;505-511.
18. Hoyer M., Jorgensen K., Bundgaard T., et al. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck. Radiother Oncol. 46:(2):1998;147-155.
19. Hsu M.M., Chiou C.R., Ko J.Y., Sheen T.S., Hong R.L., Ting L.L. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator. Cancer Detect Prev. 24:(2):2000;119-126.
20. International histological classification of tumours no 19. Histological typing of upper respiratory tract tumours: World Health Organisation; 1978. p. 32-3.
21. Johansson M.C., Johansson R., Baldetorp B., Oredsson S.M. Comparison of different labelling index formulae used on bromodeoxyuridine-flow cytometry data. Cytometry. 32:(3):1998;233-240.
22. Keng P.C., Siemann D.W. Measurement of proliferation activities in human tumor models: a comparison of flow cytometric methods. Radiat Oncol Invest. 6:(3):1998;120-127.
23. Marchal S., Marchal C., Parache R.M., et al. Combined flow cytometry and immunohistochemistry analyses for the assessment of nasopharyngeal carcinoma cell kinetics by in vivo bromodeoxyuridine infusion. Cytometry. 29:(2):1997;165-172.
24. Porter M.J., Field J.K., Lee J.C., Leung S.F., Lo D., Van Hasselt C.A. Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res. 14:(3B):1994;1357-1360.
25. Ritter M.A., Fowler J.F., Kim Y., Lindstrom M.J., Kinsella T.J. Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals. Int J Radiat Oncol Biol Phys. 23:(4):1992;811-820.
26. Teo P., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys. 36:(2):1996;291-304.
27. Teo P.M., Leung S.F., Chan A.T., et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys. 48:(5):2000;1311-1322.
28. Terry N.H., Peters L.J. The predictive value of tumor-cell kinetic parameters in radiotherapy: considerations regarding data production and analysis. J Clin Oncol. 13:(8):1995;1833-1836.
29. White R.A., Meistrich M.L. A comment on "A method to measure the duration of DNA synthesis and the potential doubling time from a single sample" Cytometry. 7:(5):1986;486-490.
30. White R.A., Terry N.H., Meistrich M.L., Calkins D.P. Improved method for computing potential doubling time from flow cytometric data. Cytometry. 11:(2):1990;314-317.
31. Yip T.T., Lau W.H., Chan J.K., et al. Prognostic significance of DNA flow cytometric analysis in patients with nasopharyngeal carcinoma. Cancer. 83:(11):1998;2284-2292.
32. Zackrisson B., Gustafsson H., Stenling R., Flygare P., Wilson G.D. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys. 38:(4):1997;677-683.
33. Zheng X., Hu L., Chen F., Christensson B. Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol. 30B:(5):1994;290-295.